The proceeds from the directed share issue strengthens Moberg Pharma’s balance sheet and enables value-creating investments, including acquisitions of additional brands/products as well as preparations for licensing and development of product candidates in clinical phase.
“We are very pleased with the interest for the new share issue and welcome our new shareholders. The new issue strengthens Moberg Pharma’s financial position and enables further investments with focus on acquisitions of established products for our U.S. operations. In the last 18 months we have completed three deals. Continued M&A activity in an integral element of our strategy”, comments
The reasons for the deviation from the shareholders’ pre-emptive rights are that the Board of the company deems it beneficial for the company and the shareholders to expand the company's institutional shareholder base, but also to capitalize on the opportunity to raise new capital to the company at attractive terms.
The subscription price has been set through a customary bookbuilding process. The subscription price entails a discount of approximately 7.3 percent in relation to the average daily price for the last 30 trading days as of the last day of trading before the decision to issue the new shares.
The new share issue in
ÖstersjÖstiftelsen, the largest shareholder of the company, has in connection with the new issue lent 2,068,965 shares to
Prospectus: The company will publish a prospectus in connection with the admission to trading of the shares issued in the new share issue. The complete prospectus is expected to be available on Moberg Pharma’s website (www.mobergpharma.se) on or about
About this information The information provided herein is such that
Important information Publication or distribution of this press release in certain jurisdictions may be subject to restrictions according to law and the people in jurisdictions where this press release has been made public or distributed should inform themselves and follow such local restrictions. This press release does not contain and does not constitute or form part of an invitation to acquire or subscribe or a solicitation of any offer to buy or subscribe for shares, subscription rights or other securities in
This press release may not be published or distributed, directly or indirectly, in or into the U.S.,
Forward-looking statements This press release contain certain forward-looking statements that reflect the company’s current view and expectations of future events and financial and operational performance, including statements regarding the directed share issue and statements regarding guidance, planning, outlook and strategies. Words such as "intends", "anticipates", "expects", "plan ", "anticipate", “can” or similar expressions regarding indications or predictions of future developments or trends, and are not based on historical facts, constitute forward-looking information. Although the company believes that these statements are based upon reasonable assumptions and expectations, the company cannot guarantee that such statements will be realized. Forward-looking statements are inherently associated with both known and unknown risks and uncertainties and future results or developments may differ materially from those set forth in forward-looking information. Forward-looking statements in the press release are only valid on the date of the press release and are subject to change without notice. The company undertakes no obligation to publicly update or revise any forward-looking statements as a result of new information or future events, other than as required by applicable law or stock market regularization. For additional information, please contact:
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Most Popular Stories
- Criminal Investigation Opened Into James Foley's Death
- The Hip New Career? Farming
- McDonald's Names Another U.S. President
- Student Startup Develops Date-rape Detector
- Sahara Casino Rises Anew as SLS Las Vegas
- Is Diversity in the Eye of the Beholder?
- Chinese Coal Gas Boom Poses Climate Risks
- U.S. Supporters of Islamic State Get Close Scrutiny
- Job Market Shifts Complicate Yellen's Rate Decision
- Dems Losing Fear of Obamacare